Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Start date: Feb 25, 2025 End date: Feb 26, 2025
Due to the recent success of New Horizons in Amyloidosis, Radcliffe Cardiology are excited to introduce a new 2-day event ‘New Horizons in Cardiomyopathy’ (NHC) in February 2025.The event, hosted on Radcliffe Cardiology, will be streamed on Tuesday 25 February - Wednesday 26February 2025. It promises an interactive and informative experience, updating professionals on cardiac amyloidosis and… View more

Heart Failure
Portrait image of Stavros Stavrakis
Research Area(s) / Expertise:

Atrial Fibrillation

 Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Dr Stavrakis is a clinical cardiac electrophysiologist and Associate Professor of Medicine at the University of Oklahoma Health Sciences Center. He is also the Director of Cardiovascular Research at the University of Oklahoma. Dr Stavrakis’ research has focused on autonomic modulation for the treatment of arrhythmias and other cardiovascular diseases, in both animal models and humans. The… View more
Decision-making in the Cardiac ICU
Author(s): Sarah Godfrey , Alexis Barnes , Jing Gao , et al Added: 1 year ago

Vascular Disease and Surgery

Heart Failure
Abhishek Joshi
Job title: Cardiac Imaging Fellow
Personal History Dr Abhishek Joshi is a Cardiologist based in London. He is a Cardiology Registrar at Barts Heart Centre and a Clinical Research Training Fellow at the British Heart Foundation. He holds a PhD in Cardiovascular Science from King’s College London. In his spare time, Dr Joshi plays the bass guitar and enjoys video games.2 Academic History In 2003, he obtained his BA… View more
Novel Therapies in ATTR-CM
Author(s): Michelle Dimza , Georgia Vasilakis , Justin L Grodin Added: 8 months ago

Heart Failure
Setting-up an HCM Clinic
Added: 2 years ago
In the first episode, Prof Juan Pablo Kaski and Prof Ruxandra Jurcut discuss the essentials of establishing an HCM Clinic, covering its objectives, logistical aspects, systemic challenges, and operational strategies, including referral practices and collaboration with specialist centres. View more

Heart Failure
Updates on Icosapent Ethyl and Cardiometabolic Risk
Author(s): Philippe Gabriel Steg , Matthew J Budoff Added: 1 year ago
Filmed onsite at ACC 2025, this on-demand series features key insights from Dr Matthew Budoff and Prof Philippe Gabriel Steg to interpret the latest data on icosapent ethyl (IPE), including a new analysis from the REDUCE-IT trial on baseline LDL-C, two new meta-analyses and a retrospective study on plaque progression in patients treated with IPE and a PCSK9 inhibitor.In these concise summaries,… View more

Heart Failure

Prevention & Chronic Conditions
His Bundle Pacing in the Era of LBBAP
Author(s): Marek Jastrzębski , Weijian Huang , Pablo Moriña Vazquez , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Heart Failure
Research Area(s) / Expertise:
Dr Saba received his MB, MCh from Cairo University's Faculty of Medicine, Egypt in 1994. He then went on to complete a house officer post at Cairo University Hospitals in 1995, completed a fellowship program and MSc degree in cardiovascular medicine from 1996 to 1999 before taking up a post as lecturer in cardiovascular medicine at Cairo University in November 1999. Dr Saba then completed an… View more
EASD 2025 Highlights: Updates on Icosapent Ethyl and Cardiometabolic Risk
Author(s): Rahul Aggarwal , Dirk Müller-Wieland Added: 9 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type… View more

Heart Failure

Prevention & Chronic Conditions